tiprankstipranks
Trending News
More News >
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF
US Market

ONO Pharmaceutical Co (OPHLF) Ratios

Compare
19 Followers

ONO Pharmaceutical Co Ratios

OPHLF's free cash flow for Q2 2026 was ¥0.73. For the 2026 fiscal year, OPHLF's free cash flow was decreased by ¥ and operating cash flow was ¥0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.99 3.99 3.99 2.81 4.27
Quick Ratio
2.50 3.52 3.52 2.44 3.63
Cash Ratio
1.30 1.60 1.60 0.78 1.05
Solvency Ratio
0.34 1.27 1.27 0.97 1.27
Operating Cash Flow Ratio
0.73 1.07 1.07 1.30 0.94
Short-Term Operating Cash Flow Coverage
3.12 47.90 0.00 -14.44 1.67
Net Current Asset Value
¥ 173.94B¥ 298.53B¥ 298.53B¥ 210.48B¥ 203.74B
Leverage Ratios
Debt-to-Assets Ratio
0.12 <0.01 <0.01 0.01 0.01
Debt-to-Equity Ratio
0.16 0.01 0.01 0.01 0.01
Debt-to-Capital Ratio
0.14 0.01 0.01 0.01 0.01
Long-Term Debt-to-Capital Ratio
0.10 0.00 0.00 >-0.01 >-0.01
Financial Leverage Ratio
1.31 1.15 1.15 1.19 1.13
Debt Service Coverage Ratio
2.22 57.66 638.79 -13.50 2.76
Interest Coverage Ratio
12.75 712.24 712.24 155.49 118.07
Debt to Market Cap
0.12 <0.01 0.00 -0.01 0.02
Interest Debt Per Share
287.05 18.94 18.94 20.65 19.49
Net Debt to EBITDA
-0.57 -0.86 -0.86 -0.52 -0.47
Profitability Margins
Gross Profit Margin
67.63%74.71%74.71%75.39%74.12%
EBIT Margin
10.83%32.62%32.62%32.30%29.31%
EBITDA Margin
18.06%36.23%36.20%37.46%35.57%
Operating Profit Margin
11.28%32.45%32.45%31.75%28.56%
Pretax Profit Margin
11.29%32.57%32.57%32.10%29.06%
Net Profit Margin
9.63%25.46%25.46%25.21%22.28%
Continuous Operations Profit Margin
9.63%25.47%25.47%25.25%22.33%
Net Income Per EBT
85.28%78.16%78.16%78.54%76.67%
EBT Per EBIT
100.06%100.39%100.39%101.11%101.77%
Return on Assets (ROA)
4.58%14.01%14.01%12.77%10.89%
Return on Equity (ROE)
6.10%16.14%16.14%15.19%12.28%
Return on Capital Employed (ROCE)
6.19%20.14%20.14%18.69%15.33%
Return on Invested Capital (ROIC)
5.10%15.66%15.70%14.87%11.13%
Return on Tangible Assets
7.18%14.94%14.94%13.86%11.94%
Earnings Yield
4.74%10.80%10.80%8.35%5.29%
Efficiency Ratios
Receivables Turnover
3.62 3.69 3.69 3.91 3.62
Payables Turnover
2.50 2.09 2.09 13.70 10.40
Inventory Turnover
2.36 2.61 2.61 2.46 2.24
Fixed Asset Turnover
4.91 4.80 4.80 4.12 3.22
Asset Turnover
0.48 0.55 0.55 0.51 0.49
Working Capital Turnover Ratio
1.88 1.89 1.89 2.04 1.96
Cash Conversion Cycle
109.33 64.17 64.17 215.35 228.92
Days of Sales Outstanding
100.74 98.80 98.80 93.37 100.79
Days of Inventory Outstanding
154.81 139.62 139.62 148.62 163.22
Days of Payables Outstanding
146.22 174.25 174.25 26.64 35.09
Operating Cycle
255.55 238.42 238.42 241.99 264.02
Cash Flow Ratios
Operating Cash Flow Per Share
217.73 230.50 230.54 326.87 124.54
Free Cash Flow Per Share
203.82 187.12 187.14 297.18 99.81
CapEx Per Share
13.91 43.39 43.39 29.69 24.73
Free Cash Flow to Operating Cash Flow
0.94 0.81 0.81 0.91 0.80
Dividend Paid and CapEx Coverage Ratio
2.32 1.91 1.91 3.61 1.55
Capital Expenditure Coverage Ratio
15.65 5.31 5.31 11.01 5.04
Operating Cash Flow Coverage Ratio
0.78 12.49 12.49 17.41 7.02
Operating Cash Flow to Sales Ratio
0.20 0.22 0.22 0.36 0.17
Free Cash Flow Yield
9.36%7.58%7.58%10.75%3.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
21.09 9.26 9.26 11.97 18.90
Price-to-Sales (P/S) Ratio
2.03 2.36 2.36 3.02 4.21
Price-to-Book (P/B) Ratio
1.27 1.49 1.49 1.82 2.32
Price-to-Free Cash Flow (P/FCF) Ratio
10.68 13.19 13.19 9.30 30.72
Price-to-Operating Cash Flow Ratio
10.00 10.71 10.71 8.46 24.62
Price-to-Earnings Growth (PEG) Ratio
1.63 0.60 0.60 0.28 2.58
Price-to-Fair Value
1.27 1.49 1.49 1.82 2.32
Enterprise Value Multiple
10.67 5.64 5.65 7.54 11.37
Enterprise Value
971.05B 1.03T 1.03T 1.26T 1.46T
EV to EBITDA
10.67 5.64 5.65 7.54 11.37
EV to Sales
1.93 2.04 2.04 2.82 4.05
EV to Free Cash Flow
10.14 11.44 11.44 8.70 29.50
EV to Operating Cash Flow
9.49 9.29 9.29 7.91 23.64
Tangible Book Value Per Share
913.09 1.54K 1.54K 1.39K 1.20K
Shareholders’ Equity Per Share
1.72K 1.65K 1.65K 1.52K 1.32K
Tax and Other Ratios
Effective Tax Rate
0.15 0.22 0.22 0.21 0.23
Revenue Per Share
1.07K 1.05K 1.05K 915.80 727.88
Net Income Per Share
103.21 266.57 266.61 230.85 162.19
Tax Burden
0.85 0.78 0.78 0.79 0.77
Interest Burden
1.04 1.00 1.00 0.99 0.99
Research & Development to Revenue
0.30 0.22 0.22 0.21 0.21
SG&A to Revenue
<0.01 0.15 0.15 0.20 0.21
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.11 0.86 0.86 1.11 0.59
Currency in JPY